Compile Data Set for Download or QSAR
Report error Found 12 Enz. Inhib. hit(s) with all data for entry = 7405
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Guangzhou Chia Tai Innovative Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 791005BDBM791005(US20260035349, Compound 1)
Affinity DataIC50: 1.30nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Guangzhou Chia Tai Innovative Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 791152BDBM791152(US20260035349, Compound 9)
Affinity DataIC50: 1.96nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Guangzhou Chia Tai Innovative Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 791154BDBM791154(US20260035349, Compound 11)
Affinity DataIC50: 25nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Guangzhou Chia Tai Innovative Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 791156BDBM791156(US20260035349, Compound 13)
Affinity DataIC50: 29.3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Guangzhou Chia Tai Innovative Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 791149BDBM791149(US20260035349, Compound 6)
Affinity DataIC50: 43.1nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Guangzhou Chia Tai Innovative Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 791151BDBM791151(US20260035349, Compound 8)
Affinity DataIC50: 51.1nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Guangzhou Chia Tai Innovative Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 791146BDBM791146(US20260035349, Compound 2)
Affinity DataIC50: 51.5nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Guangzhou Chia Tai Innovative Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 791150BDBM791150(US20260035349, Compound 7)
Affinity DataIC50: 80.2nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Guangzhou Chia Tai Innovative Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 791155BDBM791155(US20260035349, Compound 12)
Affinity DataIC50: 81.6nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Guangzhou Chia Tai Innovative Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 791153BDBM791153(US20260035349, Compound 10)
Affinity DataIC50: 298nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Guangzhou Chia Tai Innovative Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 791148BDBM791148(US20260035349, Compound 5)
Affinity DataIC50: 299nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Guangzhou Chia Tai Innovative Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 791147BDBM791147(US20260035349, Compound 4)
Affinity DataIC50: 755nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent